According to OpenAI CEO Sam Altman’s experiences shared on Microsoft founder Bill Gates’ podcast, Unconfuse Me with Bill Gates, ChatGPT shows huge commitment in three explicit industries. Altman accentuated that notwithstanding the ongoing excitement surrounding the innovation, it is still in its beginning phases and will encounter significant improvement throughout the next five to ten years.
The three industries poised to benefit the most from ChatGPT, according to Altman, are as follows:
1. Coding
Altman suggested that ChatGPT holds the potential to boost the productivity of programmers substantially. Assisting in tasks such as code review, test case writing, and code generation could potentially triple their efficiency. Beyond mere acceleration, ChatGPT aims to free up mental resources for more creative and abstract thinking, enabling programmers to explore new ideas.
Altman cautioned, however, that careful verification of ChatGPT’s outputs is crucial due to occasional inaccuracies.
2. Education
AI systems, including ChatGPT, can support teachers in curriculum design, administrative tasks, and personalized lesson planning. They can also be valuable for language learning, with companies like Duolingo incorporating AI into their methods. Gates highlighted the potential of ChatGPT in tutoring, particularly for remote and underserved communities.
Educators, however, have warned against relying solely on AI, citing potential errors and the risk of facilitating cheating.
3. Healthcare
Notwithstanding ChatGPT’s fruitful section of the US Medical Licensing Exam, an alert is encouraged because of likely mistakes. Altman recognized that the innovation is still in its beginning phases. Artificial intelligence can help medical care experts by dealing with regulatory assignments, examining research, summing up clinical narratives, and noting normal patient questions.
Prominently, pharmaceurtical organizations are presently using ChatGPT to computerize drug revelation and examination processes. The Gates Foundation intends to use such tools to address worldwide medical problems like AIDS, tuberculosis, and malaria.